Carisma Therapeutics Inc. (CARM)
$0.40 -$0.06 (-13.36%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$33.35M -
Day's Range
$0.42 - $0.48 -
Volume
329,730 -
52 Week Low / High
$0.79 - $3.16 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CARM's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $10.00
- Target Price
Company News
-
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases — Sep 10th, 2024
Building on successful pre-clinical in vivo CAR-M data in oncology, the companies will develop in vivo CAR-M for autoimmune diseases Moderna nominated two autoimmune disease targets under the collaboration Carisma is eligible to receive milestones and royalty payments PHILADELPHIA, Sep...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$